Skip to main content
Journal of Inflammation Research logoLink to Journal of Inflammation Research
. 2025 Feb 20;18:2521–2530. doi: 10.2147/JIR.S496037

IFN-γ Induces Pleural Mesothelial Cells to Recruit Immune Cells via CXCL10-CXCR3 Axis in a Mouse Pleurisy Model

Shu-Feng Dong 1,2,*, Xin-Yu Shi 1,*, Xiu-Zhi Wu 1, Feng-Shuang Yi 1,3,✉
PMCID: PMC11849421  PMID: 39995824

Abstract

Background

Pleural mesothelial cells (PMCs) form the entire surface of the pleural cavity and interact with microorganisms in the thorax. Although PMCs are known to exert multiple immune functions, their role in pleurisy remains unclear.

Methods

Pleurisy model was induced by intrapleural injection of Mycobacterium bovis bacillus Calmette-Guerin (BCG) into wild-type (WT) C57BL/6 mice. The pleural cavity was washed with Phosphate Buffered Saline (PBS) to get the immune cells. Flow cytometry was performed to identify the characteristics of the target cells.

Results

We found that IFN-γ prompts PMCs to act a summon role for the recruitment of inflammatory cells in pleurisy model. Our data showed that CD4+ T cells were the main producer of IFN-γ in the pleurisy model, and IFN-γ stimulated PMCs to recruit immune cells into the pleural cavity through the CXCL10-CXCR3 axis. In addition, IFN-γ can reshape PMCs to display macrophage-like polarization. These results revealed some new immune roles of PMCs in pleurisy.

Conclusion

In a mouse model of pleurisy, IFN-γ, which is mainly derived from CD4+ T cells, promoted PMCs to recruit of immune cells into the pleural cavity and exhibited macrophage-like polarization.

Keywords: IFN-γ, pleurisy, pleural mesothelial cells, macrophages

Introduction

Tuberculosis is one global health problem, which causes heavy burden.1 Tuberculous pleurisy is reported to be one of the most common extrapulmonary tuberculosis.2 Th-1 type immune response plays an important role in controlling tuberculosis infection,3 and IFN-γ can regulate both innate and acquired immunity to infection and exert a host’s protective response against mycobacterial infection to promote the elimination of pathogens.4

Pleural mesothelial cell (PMC) is a kind of special epithelial cell that covers the lung and inner wall of thorax.5 PMC plays a key role in maintaining normal homeostasis of the pleural space and is a central component of pathophysiological processes in the pleural cavity.6 PMC plays a critical role in initiating inflammatory responses in the pleural cavity because it is the first kind of cell to recognize perturbations in the pleural space.6 When tuberculous pleurisy occurs, several kinds of immune cells enter the subtly regulated space and form a relatively independent inflammatory environment. It is already known that PMCs are able to secret cytokines and chemokines, and adhere with immune cells in an inflammatory environment.7,8 However, the pathways that connect PMCs and immune cells remain unclear.

Macrophages are innate immune cells that digest and engulf pathogens via phagocytosis. Macrophages are highly plastic and can be polarized into different phenotypes in response to peripheral cytokines. M1 polarization results in a pro-inflammatory type, which is called “classically activated” phenotype while M2 polarization results in an anti-inflammatory type, which is called “alternatively activated” phenotype.9–11 IFN-γ is a cytokine which could drive macrophages to differentiate into the M1 phenotype.10 Here, we found that IFN-γ could also induce PMCs to exhibit macrophage-like polarization.

Materials and Methods

Mice and BCG-Induced Pleurisy

Six- to eight-week-old wild-type (WT) C57BL/6 mice were purchased from Beijing Vital River Laboratory Animal Technology (Beijing, China). The mice were housed in an environment maintained at 25°C under a 12-h light / 12-h dark cycle in the Animal Center of Capital Medical University under high health status conditions. The animal study protocol was approved by the Institutional Animal Care and Utilization Committee of Capital Medical University.

For the pleurisy models, WT mice were prepared by intrapleural injection of 5×106 bacillus Calmette-Guerin (BCG) in 100 μL saline as previously reported.12,13 Fourteen days after injection, the mice were sacrificed, and the thoracic cavities were washed with 1 mL of phosphate-buffered saline (PBS) to get the pleural lavage. The pleural lavage and blood samples were collected, and mononuclear cells were collected using Ficoll-Hypaque gradient centrifugation (Pharmacia, Uppsala, Sweden) method. The samples were then resuspended in lysis buffer (BD Biosciences, NJ, USA) and after washing with PBS, the target cells were obtained.

Isolation and Culture of Primary Pleural Mesothelial Cells

C57BL/6 mice were sacrificed and subjected to intrapleural injection of 700 μL of trypsin. Five minutes later, the trypsin was recovered and the process was repeated three times for each mouse. The samples were then centrifuged at 300× g for 6 min, and the target cells were isolated and cultured in F12k medium with 10% fetal bovine serum, as previously reported.7

For PMCs stimulation, the cells were incubated in the presence of mouse IFN-γ (20 ng/mL; PeproTech, NJ, USA) for three days, and the cells were then trypsinized and harvested for following experiments.

Cells

The Met-5A cell line was purchased from American Type Culture Collection (ATCC, VA, USA). The cells were cultured in M199 complete growth medium according to the manufacturer’s instructions and were sub-cultured at 1:2 ratios when the cells were confluent. The culture medium was changed every other day.

Flow Cytometry

The antibodies used for flow cytometry, including anti-CD3, anti-CD8, anti-CD4, anti-NK1.1, anti-B220, anti-Ly6C, anti-F4/80, anti-iNOS, anti-Arg-1, anti-calretinin, and anti-CXCR3 monoclonal antibodies were purchased from Invitrogen (Carlsbad, CA, USA) and Abcam (Cambridge, UK). The flow cytometry methods are stated in detail in previous publications.14 The FACS Canto II system (BD Biosciences) and FCS Express 5 software program (De Novo Software, CA, USA) were used to collect and analyze the data.

Next-Generation Sequencing

After stimulated with or without mouse IFN-γ (50 ng/mL) for 48 h, the PMCs culture medium supernatants were collected and frozen at −80°C, and the cells were harvested, and total RNAs were extracted using TRIzol (Invitrogen, CA, USA) following the manufacturer’s protocol. Using the Illumina NovaSeq 6000 protocol, mRNA expression profile was performed by CapitalBio Technology (Beijing, China). Two-fold change was chosen for threshold values, and 0.05 was chosen for p value to select significantly differentially expressed genes.

Concentration of CXCL10

CXCL10 levels in PMCs culture medium supernatants were tested by enzyme-linked immunosorbent assay (ELISA) kits (Laizee, Shanghai, China) in accordance with the manufacturer’s specifications.

Chemotaxis Assays

Chemotaxis assays were performed using 8-μm-pore polycarbonate filters in 24-well Transwell chambers (Corning, NY, USA). Mononuclear cells from pleural lavage were added into the upper chamber. The lower chambers were supplemented with the supernatants of IFN-γ stimulated PMCs culture medium or PBS. The cells were incubated at 37°C in 5% CO2 for 2 h. The migratory index was calculated by dividing the number of cells that migrated in response to PMCs culture medium by the number of cells that migrated in response to PBS. To investigate the role of CXCL10 in migration of mononuclear cells, 1 μg/mL anti-CXCL10 neutralizing mAb (BioLegend, CA, USA) or IgG isotype control was added to the lower chambers.

Statistical Analysis

Statistical analyses were performed with GraphPad Prism software version 8.0 (GraphPad Software, La Jolla, CA). Data were presented as means ± SEM. Student’s t test was used to perform statistical differences between groups, and p < 0.05 was considered statistically significant.

Results

CD4+ T Cells are the Main Producer of IFN-γ in BCG Induced Pleurisy

IFN-γ is an important cytokine during the protective process of microbiocidal actions.15 To verify the source of IFN-γ in pleural cavity, WT mice were intrapleural injected with 5×106 BCG to induce a pleurisy model. Fourteen days later, pleural lavage was collected and centrifuged to obtain the cells for further analysis of the proportion of IFN-γ-positive cells. Flow cytometry analysis showed that CD4+ T cells accounted for approximately 65% of the IFN-γ-positive cells (Figure 1A), and the percentage of CD4+ T cells was significantly higher than that of CD8+ T cells, NK cells, and other cells (Figure 1B), indicating that CD4+ T cells were the main producers of IFN-γ in our pleurisy model. Considering that CD4+ T cells and CD8+ T cells account for approximately 80% of IFN-γ positive cells, therefore we then examined changes in IFN-γ production by CD4+ T cells and CD8+ T cells before and after BCG injection. We found that the administration of BCG injection significantly increased the IFN-γ production by CD4+ T cells and CD8+ T cells (Figure 2A and B). In addition, previous studies also shown that BCG injection significantly increases the concentration of IFN-γ in pleural lavage in this mouse pleurisy model.3

Figure 1.

Figure 1

CD4+ T cells are the main producer of IFN-γ in BCG induced pleurisy. (A) Flow cytometric dot plots show the constituent of IFN-γ positive cells in BCG induced pleurisy. We first gated the IFN-γ positive cells, and then defined the CD3+ CD8− cells as CD4+ T cells, CD3+ CD8+ cells as CD8+ T cells and CD3− NK1.1+ cells as NK cells. Representative flow cytometric dot plots are shown from three independent experiments. (B) Column chart show the percentages of CD4+ T cells, CD8+ T cells, NK cells and other cells in IFN-γ positive cells. ****p < 0.0001 compared with control (Student’s t test). Data are shown as means ± SEM.

Figure 2.

Figure 2

CD4+ T cells (CD3+ CD8–) and CD8+ T cells (CD3+ CD8+) from pleural lavage of BCG injected mice expressed more IFN-γ than those from control mice. (A) Flow cytometric dot plots show the percentages of IFN-γ positive cells of CD4+ T cells and CD8+ T cells before and after BCG injection. We first gated the CD3+ T cells, and then defined the CD3+ CD8– cells as CD4+ T cells, CD3+ CD8+ cells as CD8+ T cells. Representative flow cytometric dot plots are shown from three independent experiments. (B) Column charts show the administration of BCG injection significantly increased the IFN-γ production by CD4+ T cells and CD8+ T cells. *p < 0.05, ***p < 0.001 compared with control (Student’s t test). Data are shown as means ± SEM.

IFN-γ Induces Pleural Mesothelial Cells to Secret CXCL10

It is reported that PMCs are able to coordinate the process of pleural inflammatory,6 so we examined the immune role of PMCs in the presence of IFN-γ. We purified PMCs from WT mice, and the PMCs showed a classic cobblestone morphology as previously reported7 (Figure 3A). The purity of PMCs was greater than 90% identified by anti-calretinin monoclonal antibody (Figure 3B and 3C). After culturing with or without IFN-γ for 2 days, the PMCs were collected and extracted total RNA for mRNA sequencing. The result showed that 548 genes were upregulated, and 586 genes were downregulated (Figure 3D) after stimulated with IFN-γ. CXCL10, an upregulated chemokine in IFN-γ stimulation group, was noticed according to the remarkable p value and its role in the persistence of inflammation.16,17 To verify the sequencing results, we used ELISA method to confirm the expression level of CXCL10 and we found a significantly elevated level of CXCL10 in the culture supernatants of both primary PMCs and Met-5A cell line after IFN-γ stimulation (Figure 3E and F).

Figure 3.

Figure 3

IFN-γ induces pleural mesothelial cells to secrete CXCL10. (A) Pleural mesothelial cells (PMCs) exhibited cobblestone morphology. (B) and (C) Flow cytometric dot plots show the purity of the PMCs. (D) Volcano plots show the differently expressed genes between the two groups. (E) and (F) Purified mouse PMCs and MeT-5A cell line were cultured with or without IFN-γ, and the CXCL10 concentrations in culture supernatant was measured by ELISA. Data are shown from three independent experiments. ****p < 0.0001 compared with control (Student’s t test). Data are shown as means ± SEM.

Expression of CXCR3 in Different Kinds of Immune Cells in BCG Induced Pleurisy

Previous research reported that the CXCL10-CXCR3 signaling axis could recruit Th1 and Th17 cells into MPE and regulate the immune response.18 Since we found that PMCs were able to secrete CXCL10 in the presence of IFN-γ, we then examined the expression of CXCR3 in immune cells from pleural lavage and blood 14 days after BCG injection (Figure 4A–E). And we found that CD4+ T cells (CD3+CD8–), CD8+ T cells (CD3+CD8+), B cells (CD3–B220+), macrophages (CD11b+F4/80+), and NK cells (CD3–NK1.1+) from pleural lavage all expressed significantly higher percentages of CXCR3 than their counterparts from blood (all p < 0.05). Based on this signaling axis, PMC-derived CXCL10 may recruit immune cells from blood into pleural cavity to exert immune functions. To verify the signaling axis, we processed a migration assay. Since it is unlikely to separate enough different kinds of immune cells from the mouse pleurisy model to carry out this experiment, we used mononuclear cells from pleural lavage of pleurisy instead. Our migration assay showed that IFN-γ stimulated PMCs culture medium supernatant attracted mononuclear cells, and the migration of the cells was significantly suppressed when anti-CXCL10 mAb was added to the medium (Figure 4F).

Figure 4.

Figure 4

Expression of CXCR3 in different kinds of immune cells. Flow cytometric dot plots of CXCR3 expression on (A) CD4+ T cells, (B) CD8+ T cells, (C) B cells, (D) Mono-macrophages and (E) NK cells in blood and pleural lavage (left panel) 14 days after intrapleural injection of BCG. The immune cells from pleural lavage express higher percentages of CXCR3 than those from blood (right panel). Representative flow cytometric dot plots are shown from three independent experiments. (F) The mononuclear cells were seeded into the top chamber, and the supernatants of PMCs culture medium with or without anti-CXCL10 mAb or an irrelevant isotype control were placed in the lower chamber of the transwell system. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 compared with blood or control (Student’s t test). Data are shown as means ± SEM.

These data indicated that PMCs may recruit CXCR3+ inflammatory cells to the pleural cavity through secreting CXCL10 induced by IFN-γ.

IFN-γ Induces PMCs to Display a Macrophage-Like Polarization

In addition to the recruitment of CXCR3+ inflammatory cells, we wondered if IFN-γ stimulation had any other effects on PMCs. Purified PMCs were isolated from WT mice and cultured with or without IFN-γ for three days. After the cells were harvested, flow cytometry data demonstrated a significantly increased expression of iNOS and decreased expression of Arg-1 in the IFN-γ stimulation group (Figure 5A and B). In this way, PMCs exhibited an M1-like polarization in the presence of IFN-γ and executed a pro-inflammatory function of recruiting immune cells via the CXCL10-CXCR3 signaling axis.

Figure 5.

Figure 5

IFN-γ induces PMCs to display a macrophage-like polarization. Purified mouse PMCs were cultured with or without IFN-γ and flow cytometric dot plots showed the expression of (A) iNOS and (B) Arg-1 (left panel). Representative flow cytometric dot plots are shown from three independent experiments. PMCs expressed higher percentages of (A) iNOS and lower percentages of (B) Arg-1 (right panel) after IFN-γ treatment. **p < 0.01 compared with control (Student’s t test). Data are shown as means ± SEM.

Discussion

Tuberculosis is still a leading cause of morbidity and mortality worldwide.19 Tuberculous pleurisy, caused by Mycobacterium tuberculosis, is a kind of inflammatory lesion of the pleura, often accompanied by chest pain and pleural effusion.20,21 Large numbers of cytokines have been studied in immune response of tuberculous pleurisy; however, a key character among these, IFN-γ, is required for protection against tuberculosis progression,22 and genetic defects in IFN-γ production or signaling are related to increased susceptibility to tuberculosis.23

IFN-γ is the only member of the type II interferon family, which is a pleiotropic cytokine. IFN-γ plays an important role in host defense against Mycobacterium tuberculosis, which enhances proinflammatory signaling by stimulating the antimicrobial action of monocytes and macrophages through initiating producing microbicidal active nitric oxide and oxygen intermediates and stimulating the production of TNF, which plays a key role in intracellular Mycobacterium tuberculosis killing.24 In addition, IFN-γ has also been shown to promote the granuloma formation and phagosome-lysosome fusion, which facilitates the death of intracellular mycobacterium.25 In this study, we investigated the source of IFN-γ in a mouse pleurisy model and we found that CD4+ T cells make up the most constituent in producing IFN-γ, in accordance with the established idea that Th1 lymphocytes play an essential role in the cure of tuberculosis infection.26,27 In addition to that, HIV patients with reduced CD4+ T cell lymphocytopenia are highly susceptible to MTB, whereas CD4+ T cell-deficient mice die quickly from uncontrolled bacterial replication and, apparently, CD4+ T cells are required to slow MTB growth.28 A recent single cell transcriptome analysis showed that Th1, CD8+ T cells and NK cells were extensively immune exhaustion in patients with severe tuberculosis, indicating that CD8+ T cells and NK cells also played a regulatory role in the progress of tuberculosis.29

PMCs physically surround the entire surface of the pleural cavity. Attached to the pleural basement membrane, the PMCs provide a frictionless free surface between the parietal and visceral serosa by secreting glycosaminoglycans and surfactants.30 Tight intercellular junctions between PMCs guarantee a protective barrier and a relatively isolated environment.31 Pleural mesothelial integrity plays an important role in limiting the spread of various pathogens. Previous studies have revealed that PMCs can produce a diverse array of mediators, such as IL-18, endostatin, β-defensin, and multiple chemokines, in response to external signals, thereby initiating and regulating inflammatory responses in an inflammatory state.32–35

In the current study, we found that IFN-γ stimulates PMCs to secrete CXCL10. CXCL10, known as IP-10 (Interferon-gamma inducible Protein 10 kDa), is secreted by various types of cells, such as T lymphocytes, neutrophils, eosinophils, macrophages, neurons, and glial cells.36 CXCL10 belongs to the CXC chemokine family and is a ligand for the CXCR3 (C-X-C motif chemokine receptor 3) receptor.37 In a published study, stimulated with Mycobacterium tuberculosis antigens, B cells were also able to produce CXCL10 by IFN-γ and T cell contact manner, which implies that CXCL10 participates in the immune response to Mycobacterium tuberculosis.38 In another study, exogenous IFN-γ induced CXCL10 production by CD3+, CD14+ and CD16+ cells from both peripheral blood mononuclear cells and pleural fluid mononuclear cells of patients with tuberculous pleurisy in a concentration-dependent manner.39 Our research has to some extent supplemented the sources of CXCL10, however, there are relative limitations of methodology in this study, as there is no pleural effusion in this mouse model, so we were unable to obtain the concentration of IFN-γ in the pleural cavity and conduct in vitro stimulation experiments based on this. But the stimulation experiments we conducted in vitro have been mutually confirmed with the subsequent experiments, so we believe that the results are reliable. Reviewing our results, we found that CD4+ T cells were the main source of IFN-γ in this pleurisy model, suggesting that CD4+ T cells may play a major role in activating PMCs through the IFN-γ pathway.

CXCL10 has been extensively studied for its role in regulating the chemotaxis of CXCR3+ immune cells.37,40 Upon binding to CXCR3, the CXCL10 / CXCR3 axis plays a pro-inflammatory role in various disease.41 In a cardiac pressure overload model, Cxcr3–/– mice prevented adverse cardiac remodeling by disrupting the infiltration of CD4+ T cells into the heart.42 This axis not only regulates immune cell migrate to the inflamed sites,43,44 but also regulates immune response in tumors. Previous research suggested that CXCL10 / CXCR3 signaling recruited tumor antigen specific CD8+ T cells to melanoma.45 In the pleurisy model, CD4+ T cells, CD8+ T cells, B cells, macrophages, and NK cells in pleural cavity all expressed a higher percentage of CXCR3 than the corresponding cells in peripheral blood. We speculated that a portion of immune cells in peripheral blood respond to PMC derived CXCL10 by upregulating CXCR3 and then chemotaxis into the thoracic cavity. This may provide a new explanation for how PMCs recruit immune cells to the thorax in this pleurisy model.

A previous report revealed that PMCs have not only secretion functions but also phagocytic function,46 which act like macrophages. Our results showed that in the presence of IFN-γ, the iNOS expression of PMCs increased, showing a M1-like polarization, and IFN-γ is also one of the inducers of M1 polarization in macrophages. Inducible NO synthase may contribute to the control of infections in the pleural space,47 and thus M1-like polarization of PMCs may be involved in pleural inflammation events. Our previous data demonstrated that PMCs can function as antigen-presenting cells.35 M1-like polarization may also be beneficial for achieving antigen presentation. Further studies should pay more attention to the mechanism of how IFN-γ inducing up-regulated expression of CXCL10 in PMCs. In brief, the results of this study reveal a role for PMCs in recruiting immune cells in the presence of IFN-γ, and provide a novel insight into the function of PMCs in pleurisy environments.

Conclusion

These results suggested that CD4+ T cells are the main source of IFN-γ in pleurisy, and IFN-γ could stimulate PMCs to produce CXCL10, thereby attracting T cells, B cells, NK cells, and monocytes from peripheral blood to the pleural cavity. IFN-γ can also cause PMCs to exhibit a macrophage-like polarized phenotype. These findings provide new insights into the PMCs’ involvement in the progression of pleurisy and might offer novel therapeutic targets for the development of pleurisy.

Funding Statement

This work was supported by grants from National Natural Science Foundation of China (no. 81900094, 82000098), Reform and Development Program of Beijing Institute of Respiratory Medicine (Ggyfz202420, Ggyfz202518).

Data Sharing Statement

The data used to support the findings of this study are available from the corresponding author Feng-Shuang Yi upon reasonable request.

Ethical Approval

The animal study protocol was approved by the Institutional Animal Care and Utilization Committee of Capital Medical University (AEEI-2023-315). The animal experiments were conducted in compliance with the Guidelines for the Care and Use of Laboratory Animals published by National Institutes of Health.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare that they have no conflicts of interest in this work.

References

  • 1.Lee CS, Li SH, Chang CH. et al. Diagnosis of tuberculosis pleurisy with three endoscopic features via pleuroscopy. Ther Adv Respir Dis. 2021;15:1753466621989532. doi: 10.1177/1753466621989532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chen S, Wang Y, Zhan Y, et al. The incidence of tuberculous pleurisy in mainland China from 2005 to 2018. Front Public Health. 2023;11:1180818. doi: 10.3389/fpubh.2023.1180818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chavez-Galan L, Vesin D, Segueni N, et al. Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model. Am J Pathol. 2016;186(9):2364–2377. doi: 10.1016/j.ajpath.2016.05.015 [DOI] [PubMed] [Google Scholar]
  • 4.Kumar R, Gandham S, Rana A, Maity HK, Sarkar U, Dey B. Divergent proinflammatory immune responses associated with the differential susceptibility of cattle breeds to tuberculosis. Front Immunol. 2023;14:1199092. doi: 10.3389/fimmu.2023.1199092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hwanga EH, Kim TH, Park JY, et al. TLR2 contributes to trigger immune response of pleural mesothelial cells against Mycobacterium bovis BCG and M. tuberculosis infection. Cytokine. 2017;95:80–87. doi: 10.1016/j.cyto.2017.02.021 [DOI] [PubMed] [Google Scholar]
  • 6.Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration. 2008;75(2):121–133. doi: 10.1159/000113629 [DOI] [PubMed] [Google Scholar]
  • 7.Mohammed KA, Nasreen N, Ward MJ, Antony VB. Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells. Am J Respir Crit Care Med. 1999;159(5):1653–1659. doi: 10.1164/ajrccm.159.5.9810011. [DOI] [PubMed] [Google Scholar]
  • 8.Nasreen N, Mohammed KA, Ward MJ, Antony VB. Mycobacterium-induced transmesothelial migration of monocytes into pleural space: role of intercellular adhesion molecule-1 in tuberculous pleurisy. J Infect Dis. 1999;180(5):1616–1623. doi: 10.1086/315057 [DOI] [PubMed] [Google Scholar]
  • 9.Shah PT, Tufail M, Wu C, Xing L. THP-1 cell line model for tuberculosis: a platform for in vitro macrophage manipulation. Tuberculosis. 2022;136:102243. doi: 10.1016/j.tube.2022.102243 [DOI] [PubMed] [Google Scholar]
  • 10.Khan A, Zhang K, Singh VK, et al. Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis. Commun Biol. 2022;5(1):480. doi: 10.1038/s42003-022-03387-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Miki H, Han KH, Scott D, Croft M, Kang YJ. 4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis. J Immunol. 2020;204(7):1892–1903. doi: 10.4049/jimmunol.1900983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Menezes-de-Lima-Júnior O, Werneck-Barroso E, Cordeiro RS, Henriques MG. Effects of inhibitors of inflammatory mediators and cytokines on eosinophil and neutrophil accumulation induced by Mycobacterium bovis bacillus Calmette-Guérin in mouse pleurisy. J Leukoc Biol. 1997;62(6):778–785. doi: 10.1002/jlb.62.6.778 [DOI] [PubMed] [Google Scholar]
  • 13.Moura AC, Werneck-Barroso E, Rosas EC, Henriques MG, Cordeiro RS. Opposite cellular accumulation and nitric oxide production in vivo after pleural immunization with M. leprae or M. bovis BCG. Int J Mol Med. 1999;3(1):69–74. doi: 10.3892/ijmm.3.1.69 [DOI] [PubMed] [Google Scholar]
  • 14.Lin H, Tong ZH, Xu QQ, et al. Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion. Am J Respir Crit Care Med. 2014;189(6):697–706. doi: 10.1164/rccm.201310-1776OC [DOI] [PubMed] [Google Scholar]
  • 15.Periago MV, Kiflie A, Bewket G, et al. 2023-PLoS Negl Trop Dis-IFNγ. PLoS Negl Trop Dis. 2023;17(1). doi: 10.1371/journal.pntd.0011094 [DOI] [Google Scholar]
  • 16.Motamed-Sanaye A, Khazaee YF, Shokrgozar M, Alishahi M, Ahramiyanpour N, Amani M. JAK inhibitors in lichen planus: a review of pathogenesis and treatments. J DermatolTreat. 2022;33(8):3098–3103. doi: 10.1080/09546634.2022.2116926 [DOI] [PubMed] [Google Scholar]
  • 17.Zhou L, Zhang YF, Yang FH, Mao HQ, Chen Z, Zhang L. Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway. Cell Commun Signal. 2021;19(1):58. doi: 10.1186/s12964-021-00738-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kiflie A, Bewket G, Tajebe F, Abate E, Schӧn T, Blomgran R. Helminth species-specific effects on IFN-γ producing T cells during active and latent tuberculosis. PLoS Negl Trop Dis. 2023;17(1):e0011094. doi: 10.1371/journal.pntd.0011094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Li J, Jin C, Wu C, Huang J. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy. J Leukoc Biol. 2019;106(3):733–747. doi: 10.1002/jlb.Ma1118-450rr [DOI] [PubMed] [Google Scholar]
  • 20.Du WL, Liang JQ, Yang XT, et al. Accuracy of cell-free Mycobacterium tuberculosis DNA testing in pleural effusion for diagnosing tuberculous pleurisy: a multicenter cross-sectional study. Mil Med Res. 2024;11(1):60. doi: 10.1186/s40779-024-00567-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Niu Q, Wang M, Liu XS. The evolving landscape of IL-10, IL-22 and IL-26 in pleurisy especially in tuberculous pleurisy. Respir Res. 2024;25(1):275. doi: 10.1186/s12931-024-02896-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178(6):2249–2254. doi: 10.1084/jem.178.6.2249 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620. doi: 10.1146/annurev.immunol.20.081501.125851 [DOI] [PubMed] [Google Scholar]
  • 24.Mishra BB, Rathinam VA, Martens GW, et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol. 2013;14(1):52–60. doi: 10.1038/ni.2474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ghanavi J, Farnia P, Farnia P, Velayati AA. The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections. Int J Mycobacteriol. 2021;10(4):349–357. doi: 10.4103/ijmy.ijmy_186_21 [DOI] [PubMed] [Google Scholar]
  • 26.Guo S, Zhao J. Immunotherapy for tuberculosis: what’s the better choice?. Frontiers in Bioscience (Landmark Edition). 2012;17(7):2684–2690. doi: 10.2741/4079 [DOI] [PubMed] [Google Scholar]
  • 27.Perreau M, Rozot V, Welles HC, et al. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease. Eur J Immunol. 2013;43(4):939–948. doi: 10.1002/eji.201243090 [DOI] [PubMed] [Google Scholar]
  • 28.Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol. 2011;186(3):1598–1607. doi: 10.4049/jimmunol.1003304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wang Y, Sun Q, Zhang Y, et al. Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas. J Infect. 2023;86(5):421–438. doi: 10.1016/j.jinf.2023.03.020 [DOI] [PubMed] [Google Scholar]
  • 30.Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology. 2002;7(3):171–191. doi: 10.1046/j.1440-1843.2002.00404.x [DOI] [PubMed] [Google Scholar]
  • 31.Donnenberg VS, Luketich JD, Popov B, Bartlett DL, Donnenberg AD. A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting. Front Immunol. 2024;15:1404373. doi: 10.3389/fimmu.2024.1404373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Song CH, Lee JS, Nam HH, et al. IL-18 production in human pulmonary and pleural tuberculosis. Scand J Immunol. 2002;56(6):611–618. doi: 10.1046/j.1365-3083.2002.01143.x [DOI] [PubMed] [Google Scholar]
  • 33.Nasreen N, Mohammed KA, Brown S, et al. Talc mediates angiostasis in malignant pleural effusions via endostatin induction. Eur Respir J. 2007;29(4):761–769. doi: 10.1183/09031936.00061606 [DOI] [PubMed] [Google Scholar]
  • 34.Hussain T, Nasreen N, Lai Y, Bellew BF, Antony VB, Mohammed KA. Innate immune responses in murine pleural mesothelial cells: toll-like receptor-2 dependent induction of beta-defensin-2 by staphylococcal peptidoglycan. Am J Physiol Lung Cell mol Physiol. 2008;295(3):L461–70. doi: 10.1152/ajplung.00276.2007 [DOI] [PubMed] [Google Scholar]
  • 35.Ye ZJ, Zhou Q, Yuan ML, et al. Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy. Am J Respir Crit Care Med. 2012;185(6):660–669. doi: 10.1164/rccm.201107-1198OC [DOI] [PubMed] [Google Scholar]
  • 36.Qiao X, Zhang W, Zhao W. Role of CXCL10 in Spinal Cord Injury. Int J Med Sci. 2022;19(14):2058–2070. doi: 10.7150/ijms.76694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pandey V, Fleming-Martinez A, Bastea L, et al. CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions. Elife. 2021;10:60646. doi: 10.7554/eLife.60646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hoff ST, Salman AM, Ruhwald M, et al. Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells. Tuberculosis. 2015;95(1):40–47. doi: 10.1016/j.tube.2014.10.005 [DOI] [PubMed] [Google Scholar]
  • 39.Wu C, Ma J, Xu Y, Zhang X, Lao S, Yang B. Pleural fluid mononuclear cells (PFMCs) from tuberculous pleurisy can migrate in vitro in response to CXCL10. Tuberculosis. 2014;94(2):123–130. doi: 10.1016/j.tube.2013.10.008 [DOI] [PubMed] [Google Scholar]
  • 40.Shang C, Sun Y, Wang Y, et al. CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis. Cancer Lett. 2022;537:215667. doi: 10.1016/j.canlet.2022.215667 [DOI] [PubMed] [Google Scholar]
  • 41.Elemam NM, Talaat IM, Maghazachi AA. CXCL10 Chemokine: a Critical Player in RNA and DNA Viral Infections. Viruses. 2022;14(11):2445. doi: 10.3390/v14112445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ngwenyama N, Salvador AM, Velázquez F, et al. CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction. JCI Insight. 2019;4(7):125527. doi: 10.1172/jci.insight.125527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Tokunaga R, Zhang W, Naseem M, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–47. doi: 10.1016/j.ctrv.2017.11.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Gudowska-Sawczuk M, Mroczko B. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? Int J mol Sci. 2022;23(7):3673. doi: 10.3390/ijms23073673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Reschke R, Yu J, Flood B, Higgs EF, Hatogai K, Gajewski TF. Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. J Immunother Cancer. 2021;9(9):e003521. doi: 10.1136/jitc-2021-003521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Jaurand MC, Kaplan H, Thiollet J, Pinchon MC, Bernaudin JF, Bignon J. Phagocytosis of chrysotile fibers by pleural mesothelial cells in culture. Am J Pathol. 1979;94(3):529–538. [PMC free article] [PubMed] [Google Scholar]
  • 47.Batra H, Antony VB. Pleural mesothelial cells in pleural and lung diseases. J Thorac Dis. 2015;7(6):964–980. doi: 10.3978/j.issn.2072-1439.2015.02.19 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data used to support the findings of this study are available from the corresponding author Feng-Shuang Yi upon reasonable request.


Articles from Journal of Inflammation Research are provided here courtesy of Dove Press

RESOURCES